Baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) induce autophagy in MCF-7 cells via ROS-mediated p38 MAPK and Akt/mTOR pathway
Background Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous solubility and unknown mechanism of action limit its application. This study aimed to investigate the antiproliferative effects of baicalin-l...
Saved in:
Published in | Cancer nanotechnology Vol. 13; no. 1; pp. 1 - 21 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Vienna
Springer Vienna
01.12.2022
Springer Nature B.V BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1868-6958 1868-6966 |
DOI | 10.1186/s12645-021-00110-x |
Cover
Abstract | Background
Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous solubility and unknown mechanism of action limit its application. This study aimed to investigate the antiproliferative effects of baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) in breast cancer MCF-7 cells and its relationship with autophagy and ROS-mediated p38 MAPK and Akt/mTOR signaling pathways. Cell viability was detected by MTT assay. Flow cytometry and fluorescence microscopy were used to detect cell cycle, apoptosis and autophagy. Western blot was used to detect protein expression.
Results
Compared with the control and free baicalin groups, FA-BSANPs/BA inhibited viability of MCF-7 cells and increased cells in S phase, apoptotic bodies, pro-apoptotic proteins, autophagy markers and autophagosomes. These effects could be reversed when combined with the autophagy inhibitor 3-methyladenine. FA-BSANPs/BA increased the levels of phosphorylated p38 MAPK, inhibited the levels of phosphorylated Akt and mTOR, and increased the level of ROS in MCF-7 cells. The effects of FA-BSANPs/BA could be reversed or enhanced using inhibitors of Akt, mTOR, p38 MAPK and ROS scavengers.
Conclusions
Encapsulation in folate albumin nanoparticles improved the antiproliferative activity of baicalin. FA-BSANPs/BA induced autophagy and apoptosis via ROS-mediated p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. |
---|---|
AbstractList | BackgroundBreast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous solubility and unknown mechanism of action limit its application. This study aimed to investigate the antiproliferative effects of baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) in breast cancer MCF-7 cells and its relationship with autophagy and ROS-mediated p38 MAPK and Akt/mTOR signaling pathways. Cell viability was detected by MTT assay. Flow cytometry and fluorescence microscopy were used to detect cell cycle, apoptosis and autophagy. Western blot was used to detect protein expression.ResultsCompared with the control and free baicalin groups, FA-BSANPs/BA inhibited viability of MCF-7 cells and increased cells in S phase, apoptotic bodies, pro-apoptotic proteins, autophagy markers and autophagosomes. These effects could be reversed when combined with the autophagy inhibitor 3-methyladenine. FA-BSANPs/BA increased the levels of phosphorylated p38 MAPK, inhibited the levels of phosphorylated Akt and mTOR, and increased the level of ROS in MCF-7 cells. The effects of FA-BSANPs/BA could be reversed or enhanced using inhibitors of Akt, mTOR, p38 MAPK and ROS scavengers.ConclusionsEncapsulation in folate albumin nanoparticles improved the antiproliferative activity of baicalin. FA-BSANPs/BA induced autophagy and apoptosis via ROS-mediated p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Background Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous solubility and unknown mechanism of action limit its application. This study aimed to investigate the antiproliferative effects of baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) in breast cancer MCF-7 cells and its relationship with autophagy and ROS-mediated p38 MAPK and Akt/mTOR signaling pathways. Cell viability was detected by MTT assay. Flow cytometry and fluorescence microscopy were used to detect cell cycle, apoptosis and autophagy. Western blot was used to detect protein expression. Results Compared with the control and free baicalin groups, FA-BSANPs/BA inhibited viability of MCF-7 cells and increased cells in S phase, apoptotic bodies, pro-apoptotic proteins, autophagy markers and autophagosomes. These effects could be reversed when combined with the autophagy inhibitor 3-methyladenine. FA-BSANPs/BA increased the levels of phosphorylated p38 MAPK, inhibited the levels of phosphorylated Akt and mTOR, and increased the level of ROS in MCF-7 cells. The effects of FA-BSANPs/BA could be reversed or enhanced using inhibitors of Akt, mTOR, p38 MAPK and ROS scavengers. Conclusions Encapsulation in folate albumin nanoparticles improved the antiproliferative activity of baicalin. FA-BSANPs/BA induced autophagy and apoptosis via ROS-mediated p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Abstract Background Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous solubility and unknown mechanism of action limit its application. This study aimed to investigate the antiproliferative effects of baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) in breast cancer MCF-7 cells and its relationship with autophagy and ROS-mediated p38 MAPK and Akt/mTOR signaling pathways. Cell viability was detected by MTT assay. Flow cytometry and fluorescence microscopy were used to detect cell cycle, apoptosis and autophagy. Western blot was used to detect protein expression. Results Compared with the control and free baicalin groups, FA-BSANPs/BA inhibited viability of MCF-7 cells and increased cells in S phase, apoptotic bodies, pro-apoptotic proteins, autophagy markers and autophagosomes. These effects could be reversed when combined with the autophagy inhibitor 3-methyladenine. FA-BSANPs/BA increased the levels of phosphorylated p38 MAPK, inhibited the levels of phosphorylated Akt and mTOR, and increased the level of ROS in MCF-7 cells. The effects of FA-BSANPs/BA could be reversed or enhanced using inhibitors of Akt, mTOR, p38 MAPK and ROS scavengers. Conclusions Encapsulation in folate albumin nanoparticles improved the antiproliferative activity of baicalin. FA-BSANPs/BA induced autophagy and apoptosis via ROS-mediated p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. |
ArticleNumber | 2 |
Author | Zou, Tengteng Kong, Zhaodi Lan, Meng Fan, Dongmei Cai, Tiange Cai, Yu Liu, Fengjie Ren, Baoqi Li, Lihong |
Author_xml | – sequence: 1 givenname: Fengjie surname: Liu fullname: Liu, Fengjie organization: College of Pharmacy, Jinan University – sequence: 2 givenname: Meng surname: Lan fullname: Lan, Meng organization: College of Pharmacy, Jinan University – sequence: 3 givenname: Baoqi surname: Ren fullname: Ren, Baoqi organization: Medical Department of Guangdong Hospital of Traditional Chinese Medicine – sequence: 4 givenname: Lihong surname: Li fullname: Li, Lihong organization: College of Pharmacy, Jinan University – sequence: 5 givenname: Tengteng surname: Zou fullname: Zou, Tengteng organization: College of Pharmacy, Jinan University – sequence: 6 givenname: Zhaodi surname: Kong fullname: Kong, Zhaodi organization: College of Pharmacy, Jinan University – sequence: 7 givenname: Dongmei surname: Fan fullname: Fan, Dongmei email: dongmeifan9@sina.com organization: Department of Gastroenterology, First Affiliated Hospital of Guangzhou University of Chinese Medicine – sequence: 8 givenname: Tiange surname: Cai fullname: Cai, Tiange email: caitiange@163.com organization: College of Life Sciences, Liaoning University – sequence: 9 givenname: Yu orcidid: 0000-0002-8532-7816 surname: Cai fullname: Cai, Yu email: caiyu8@sohu.com organization: College of Pharmacy, Jinan University, Guangdong Key Lab of Traditional Chinese Medicine Information Technology, Jinan University |
BookMark | eNp9kc1u1DAUhSNUJErpC7CyxAYWZmwncZxlZtSBipap2tlbN_6ZekjsEGeg8yS8Lm6naqUu6o2t4_ude6_O--zIB2-y7CMlXykVfBYp40WJCaOYEEoJvnuTHacPgXnN-dHTuxTvstMYtySdvK5rUh9n_-bgFHTO4y6ANhrZ0DmFQDmN-6CddUmDrt31ziMPPgwwTk51JqLPywbPb5qfV3E2b74g5_VOGQS7KQy3sNknAV0ulrhCynRdRH8coOvVDe6NdjAl1yEX6LK5-oHAa9T8mmb9enWNBphu_8L-Q_bWQhfN6eN9kq2XZ-vFd3yx-na-aC6wKlg9YVpCbanKFbFc68LSsjIWqBaW5Zwxog0npK2qVqiqTGuD4oLbWrTcVDkT-Ul2frDVAbZyGF0P414GcPJBCONGPu4rQQmrmGqpoFDoVtetKC3lghWUlLW99_p08BrG8Htn4iS3YTf6NL1knFaUMlqxVMUOVWoMMY7GPnWlRN7HKQ9xyhSnfIhT3iVIvICUm2BywU8juO51ND-gMfXxGzM-T_UK9R99k7TZ |
CitedBy_id | crossref_primary_10_3390_cells12030458 crossref_primary_10_1016_j_ecoenv_2024_116973 crossref_primary_10_1002_smll_202310966 crossref_primary_10_1007_s12272_022_01397_z crossref_primary_10_3390_cimb47030181 crossref_primary_10_1016_j_onano_2022_100081 crossref_primary_10_1016_j_ijbiomac_2025_140627 crossref_primary_10_1038_s41598_024_62409_0 crossref_primary_10_1186_s12645_023_00181_y crossref_primary_10_3390_pharmaceutics15041186 crossref_primary_10_1080_17425247_2022_2139370 crossref_primary_10_1016_j_cbi_2024_111356 crossref_primary_10_1007_s11033_024_09325_8 crossref_primary_10_1016_j_jddst_2023_104161 crossref_primary_10_1088_1361_6528_adad7a crossref_primary_10_1016_j_ccr_2024_215754 crossref_primary_10_1002_cbdv_202301122 crossref_primary_10_1016_j_ijpharm_2024_124919 crossref_primary_10_1080_09205063_2024_2429325 crossref_primary_10_1016_j_biopha_2024_117327 crossref_primary_10_1186_s12645_023_00237_z crossref_primary_10_1016_j_sbsr_2023_100571 crossref_primary_10_1007_s00210_023_02907_6 crossref_primary_10_1016_j_mtcomm_2022_104561 crossref_primary_10_1016_j_ijbiomac_2025_140038 crossref_primary_10_1515_biol_2022_1000 crossref_primary_10_3390_ph16010092 crossref_primary_10_1016_j_apsb_2024_03_019 crossref_primary_10_1002_cbdv_202301767 crossref_primary_10_1002_cbin_12081 |
Cites_doi | 10.1007/s11010-019-03667-9 10.1016/j.ctrv.2008.09.005 10.2147/OTT.S217101 10.3892/mmr.2017.7757 10.1038/nrd2803 10.1038/aps.2009.166 10.2147/DDDT.S176403 10.1016/j.jddst.2021.102603 10.1016/S0378-5173(03)00134-0 10.1016/j.phrs.2010.10.012 10.1007/s12272-010-0809-x 10.1016/j.semcdb.2017.05.023 10.1146/annurev-immunol-042617-053010 10.3322/caac.21590 10.1038/s41419-019-1492-6 10.1016/j.biopha.2019.109139 10.3390/nu11071514 10.1186/s12943-020-1138-4 10.18632/oncotarget.27677 10.3892/or.2011.1599 10.1186/s11671-016-1586-3 10.1007/s10495-017-1424-9 10.1001/jama.2018.19323 10.1089/ars.2013.5746 10.1016/j.cmet.2017.04.004 10.1016/j.jmb.2016.02.027 10.1016/j.canlet.2013.11.019 10.1016/j.ijpharm.2004.08.015 10.1080/21691401.2018.1548468 10.1038/s41571-020-0341-y 10.1155/2016/5293284 10.1016/j.canlet.2016.03.042 10.1016/j.cis.2017.06.012 10.3390/ijms18051088 10.1016/j.phrs.2020.105387 10.3390/pharmaceutics12020107 10.1039/C8TB02477D |
ContentType | Journal Article |
Copyright | The Author(s) 2022 The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2022 – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION 3V. 7X7 7XB 8AO 8FE 8FG 8FI 8FJ 8FK ABJCF ABUWG AFKRA AZQEC BENPR BGLVJ CCPQU DWQXO FYUFA GHDGH HCIFZ K9. L6V M0S M7S PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS PTHSS DOA |
DOI | 10.1186/s12645-021-00110-x |
DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central Technology Collection ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) SciTech Collection (ProQuest) ProQuest Health & Medical Complete (Alumni) ProQuest Engineering Collection Health & Medical Collection (Alumni) Engineering Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Directory of Open Access Journals (DOAJ) |
DatabaseTitle | CrossRef Publicly Available Content Database Technology Collection ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Engineering Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) Engineering Collection Engineering Database ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Materials Science & Engineering Collection ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1868-6966 |
EndPage | 21 |
ExternalDocumentID | oai_doaj_org_article_ac8fc2cb181a4dbd9b85f168241059f8 10_1186_s12645_021_00110_x |
GrantInformation_xml | – fundername: projects of international cooperation and exchanges of national natural science foundation of china grantid: 82020108033 – fundername: natural science foundation of guangdong grantid: 2019A1515011286 |
GroupedDBID | --- -58 -5G -A0 -BR 0R~ 0VY 1N0 2JY 2VQ 30V 3V. 4.4 408 409 40D 7X7 875 8AO 8FE 8FG 8FI 8FJ 8TC AAFWJ AAJSJ AAKKN AAYZH ABEEZ ABJCF ABUWG ACACY ACGFS ACIWK ACULB ADBBV ADINQ ADUKV AFGXO AFKRA AFWTZ AGJBK AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH BAPOH BCNDV BENPR BFQNJ BGLVJ BGNMA BMC BPHCQ BVXVI C24 C6C CCPQU EBLON EBS EJD F5P FYUFA GQ6 GQ8 GROUPED_DOAJ HCIFZ HF~ HMCUK HMJXF HZ~ IZIGR KOV L6V M4Y M7S M~E NU0 O9- O93 OK1 P9N PIMPY PQQKQ PROAC PTHSS QOS R9I RSV S1Z S27 S3B SCM SOJ T13 TSV TUS U2A UKHRP WK8 Z45 Z85 ~A9 AASML AAYXX AFPKN CITATION PHGZM PHGZT 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQGLB PQUKI PRINS PUEGO |
ID | FETCH-LOGICAL-c429t-15a9f1c3c0f6dd4f157efa1d8f236220de600b77b8c75000ac686f98b6e73283 |
IEDL.DBID | 7X7 |
ISSN | 1868-6958 |
IngestDate | Wed Aug 27 01:27:46 EDT 2025 Fri Jul 25 11:04:51 EDT 2025 Tue Jul 01 02:42:20 EDT 2025 Thu Apr 24 23:13:56 EDT 2025 Fri Feb 21 02:46:32 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Albumin nanoparticles Signal pathway Breast cancer Autophagy Baicalin |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c429t-15a9f1c3c0f6dd4f157efa1d8f236220de600b77b8c75000ac686f98b6e73283 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
ORCID | 0000-0002-8532-7816 |
OpenAccessLink | https://www.proquest.com/docview/2617112172?pq-origsite=%requestingapplication% |
PQID | 2617112172 |
PQPubID | 2034790 |
PageCount | 21 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ac8fc2cb181a4dbd9b85f168241059f8 proquest_journals_2617112172 crossref_primary_10_1186_s12645_021_00110_x crossref_citationtrail_10_1186_s12645_021_00110_x springer_journals_10_1186_s12645_021_00110_x |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-12-01 |
PublicationDateYYYYMMDD | 2022-12-01 |
PublicationDate_xml | – month: 12 year: 2022 text: 2022-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Vienna |
PublicationPlace_xml | – name: Vienna – name: Heidelberg |
PublicationSubtitle | Basic,Translational and Clinical Research |
PublicationTitle | Cancer nanotechnology |
PublicationTitleAbbrev | Cancer Nano |
PublicationYear | 2022 |
Publisher | Springer Vienna Springer Nature B.V BMC |
Publisher_xml | – name: Springer Vienna – name: Springer Nature B.V – name: BMC |
References | Waks, Winer (CR30) 2019; 321 Wei, Xiaojun, Peilong (CR31) 2020; 121 Langer, Balthasar, Vogel, Dinauer, von Briesen, Schubert (CR12) 2003; 257 Ahmed, Rashed, Fayez, Farouk, Shamma (CR1) 2020 De Cicco, Catani, Gasperi, Sibilano, Quaglietta, Savini (CR4) 2019 Siegel, Miller, Jemal (CR25) 2020; 70 Duan, Guo, Pei, Wang, Li, Xiong (CR5) 2019; 12 Li-Weber (CR17) 2009; 35 Kimmelman, White (CR11) 2017; 25 Zhang, Hou, Zhang, Hu, Wang (CR35) 2010; 33 Sui, Kong, Ye, Han, Zhou, Zhang (CR27) 2014; 344 Li, He, Ma (CR14) 2020; 19 Mancias, Kimmelman (CR18) 2016; 428 Shen, Li, Kohama, Oneill, Bi (CR24) 2011; 63 Tao, Chuah, Xu, Wang (CR28) 2019; 7 Zhu, Fang, Wang, Fei, Tang, Liu (CR41) 2018; 12 Yang, Lian (CR33) 2020; 467 Gao, Zhou, Li, Cong, Jiang, Wang (CR6) 2017; 16 Gao, Liu, Wang, Hu, He, Gu (CR7) 2018; 53 Kim, Park, Kim, Yu, Park, Kim (CR10) 2017 Moloney, Cotter (CR20) 2018; 80 Singh, Meena, Luqman (CR26) 2021; 164 Zou, Chang, Li, Wang (CR42) 2017; 22 Lee, Ko, Hwang, Heo, Lee, Heo (CR13) 2016; 11 Zhou, Zhang, Kuang, Gong, Jiang, Lin (CR40) 2017; 38 Meng, Liu, Lan, Zou, Li, Cai (CR19) 2021; 65 Trachootham, Alexandre, Huang (CR29) 2009; 8 Kaminskyy, Zhivotovsky (CR9) 2014; 21 Xiang, Zhang, Jin, Tian, Cheng, Wang (CR32) 2020; 45 Nagata (CR21) 2018; 36 Zhang, He, Ye, Zhu, Hu, Shen (CR37) 2019; 10 Peng, Fu, Guo, Zhang, Di, Jiang (CR22) 2015; 14 Zhang, Hou, Mao, Wei, Song, Lu (CR34) 2004; 287 Hung, Pan, Hu (CR8) 2016; 2016 Zhang, Tang, Liu, Li, Hou, Gao (CR36) 2012; 27 Liu, Dong, Liu, Xiao (CR16) 2020; 11 Zhao, Zhao, Zu, Li, Zhang, Jiang (CR38) 2010; 5 Bhushan, Khanadeev, Khlebtsov, Khlebtsov, Gopinath (CR2) 2017; 246 Zhou, Wang, Zhang, Lu, Wang, Motoo (CR39) 2009; 30 Lian, Wu, Feng, Deng, Zhong, Zhao (CR15) 2019; 47 Carneiro, El-Deiry (CR3) 2020; 17 Prasad, Gupta, Tyagi (CR23) 2017; 387 X Duan (110_CR5) 2019; 12 S Yang (110_CR33) 2020; 467 G Zhang (110_CR37) 2019; 10 D Zhao (110_CR38) 2010; 5 F Meng (110_CR19) 2021; 65 S Nagata (110_CR21) 2018; 36 X Sui (110_CR27) 2014; 344 JN Moloney (110_CR20) 2018; 80 P De Cicco (110_CR4) 2019 C Gao (110_CR6) 2017; 16 S Prasad (110_CR23) 2017; 387 L Zhang (110_CR34) 2004; 287 RL Siegel (110_CR25) 2020; 70 Z Shen (110_CR24) 2011; 63 B Lian (110_CR15) 2019; 47 D Trachootham (110_CR29) 2009; 8 T Zhou (110_CR40) 2017; 38 D-K Liu (110_CR16) 2020; 11 Y Zhu (110_CR41) 2018; 12 B Bhushan (110_CR2) 2017; 246 Y-C Hung (110_CR8) 2016; 2016 AC Kimmelman (110_CR11) 2017; 25 K Langer (110_CR12) 2003; 257 Y Gao (110_CR7) 2018; 53 VO Kaminskyy (110_CR9) 2014; 21 JD Mancias (110_CR18) 2016; 428 C Tao (110_CR28) 2019; 7 Q Zhou (110_CR39) 2009; 30 IS Ahmed (110_CR1) 2020 BA Carneiro (110_CR3) 2020; 17 Y Peng (110_CR22) 2015; 14 D Lee (110_CR13) 2016; 11 L Zhang (110_CR35) 2010; 33 W Xiang (110_CR32) 2020; 45 X Li (110_CR14) 2020; 19 M Li-Weber (110_CR17) 2009; 35 Z Zou (110_CR42) 2017; 22 T Wei (110_CR31) 2020; 121 X Zhang (110_CR36) 2012; 27 S Singh (110_CR26) 2021; 164 K-Y Kim (110_CR10) 2017 AG Waks (110_CR30) 2019; 321 |
References_xml | – volume: 467 start-page: 1 issue: 1–2 year: 2020 end-page: 12 ident: CR33 article-title: ROS and diseases: role in metabolism and energy supply publication-title: Mol Cell Biochem doi: 10.1007/s11010-019-03667-9 – volume: 35 start-page: 57 issue: 1 year: 2009 end-page: 68 ident: CR17 article-title: New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2008.09.005 – volume: 12 start-page: 11183 year: 2019 end-page: 11193 ident: CR5 article-title: Baicalin inhibits cell viability, migration and invasion in breast cancer by regulating miR-338-3p and MORC4 publication-title: Onco Targets Ther doi: 10.2147/OTT.S217101 – volume: 16 start-page: 8729 issue: 6 year: 2017 end-page: 8734 ident: CR6 article-title: Antitumor effects of baicalin on ovarian cancer cells through induction of cell apoptosis and inhibition of cell migration in vitro publication-title: Mol Med Rep doi: 10.3892/mmr.2017.7757 – volume: 45 start-page: 245 issue: 1 year: 2020 end-page: 254 ident: CR32 article-title: RCE-4, a potential anti-cervical cancer drug isolated from Reineckia carnea, induces autophagy via the dual blockade of PI3K and ERK pathways in cervical cancer CaSki cells publication-title: Int J Mol Med – volume: 8 start-page: 579 issue: 7 year: 2009 end-page: 591 ident: CR29 article-title: Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2803 – volume: 30 start-page: 1648 issue: 12 year: 2009 end-page: 1658 ident: CR39 article-title: The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2009.166 – volume: 12 start-page: 3247 year: 2018 end-page: 3261 ident: CR41 article-title: Baicalin suppresses proliferation, migration, and invasion in human glioblastoma cells via Ca(2+)-dependent pathway publication-title: Drug Des Devel Ther doi: 10.2147/DDDT.S176403 – volume: 65 start-page: 102603 year: 2021 ident: CR19 article-title: Preparation and evaluation of folate-modified albumin baicalin-loaded nanoparticles for the targeted treatment of breast cancer publication-title: J Drug Deliv Sci Technol. doi: 10.1016/j.jddst.2021.102603 – volume: 257 start-page: 169 issue: 1–2 year: 2003 end-page: 180 ident: CR12 article-title: Optimization of the preparation process for human serum albumin (HSA) nanoparticles publication-title: Int J Pharm doi: 10.1016/S0378-5173(03)00134-0 – volume: 5 start-page: 669 year: 2010 end-page: 677 ident: CR38 article-title: Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles publication-title: Int J Nanomedicine – volume: 63 start-page: 51 issue: 1 year: 2011 end-page: 58 ident: CR24 article-title: Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres publication-title: Pharmacol Res doi: 10.1016/j.phrs.2010.10.012 – volume: 33 start-page: 1193 issue: 8 year: 2010 end-page: 1198 ident: CR35 article-title: Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles publication-title: Arch Pharm Res doi: 10.1007/s12272-010-0809-x – volume: 80 start-page: 50 year: 2018 end-page: 64 ident: CR20 article-title: ROS signalling in the biology of cancer publication-title: Semin Cell Dev Biol doi: 10.1016/j.semcdb.2017.05.023 – volume: 36 start-page: 489 year: 2018 end-page: 517 ident: CR21 article-title: Apoptosis and clearance of apoptotic cells publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-042617-053010 – volume: 14 start-page: 251 issue: 1 year: 2015 end-page: 261 ident: CR22 article-title: Effects and mechanism of baicalin on apoptosis of cervical cancer hela cells in-vitro publication-title: Iran J Pharm Res – volume: 70 start-page: 7 issue: 1 year: 2020 end-page: 30 ident: CR25 article-title: Cancer statistics, 2020 publication-title: CA Cancer J Clin doi: 10.3322/caac.21590 – volume: 10 start-page: 255 issue: 4 year: 2019 ident: CR37 article-title: β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma publication-title: Cell Death Dis doi: 10.1038/s41419-019-1492-6 – volume: 121 start-page: 109139 year: 2020 ident: CR31 article-title: Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2019.109139 – year: 2019 ident: CR4 article-title: Nutrition and breast cancer: a literature review on prevention, treatment and recurrence publication-title: Nutrients doi: 10.3390/nu11071514 – volume: 19 start-page: 12 issue: 1 year: 2020 ident: CR14 article-title: Autophagy and autophagy-related proteins in cancer publication-title: Mol Cancer doi: 10.1186/s12943-020-1138-4 – volume: 11 start-page: 2863 issue: 29 year: 2020 end-page: 2872 ident: CR16 article-title: Baicalin inhibits the TGF-β1/p-Smad3 pathway to suppress epithelial-mesenchymal transition-induced metastasis in breast cancer publication-title: Oncotarget doi: 10.18632/oncotarget.27677 – volume: 27 start-page: 1128 issue: 4 year: 2012 end-page: 1134 ident: CR36 article-title: Autophagy induced by baicalin involves downregulation of CD147 in SMMC-7721 cells in vitro publication-title: Oncol Rep doi: 10.3892/or.2011.1599 – volume: 11 start-page: 381 issue: 1 year: 2016 ident: CR13 article-title: Use of baicalin-conjugated gold nanoparticles for apoptotic induction of breast cancer cells publication-title: Nanoscale Res Lett doi: 10.1186/s11671-016-1586-3 – volume: 22 start-page: 1321 issue: 11 year: 2017 end-page: 1335 ident: CR42 article-title: Induction of reactive oxygen species: an emerging approach for cancer therapy publication-title: Apoptosis doi: 10.1007/s10495-017-1424-9 – volume: 53 start-page: 2727 issue: 6 year: 2018 end-page: 2736 ident: CR7 article-title: Baicalin inhibits breast cancer development via inhibiting IĸB kinase activation in vitro and in vivo publication-title: Int J Oncol – volume: 321 start-page: 288 issue: 3 year: 2019 end-page: 300 ident: CR30 article-title: Breast cancer treatment: a review publication-title: JAMA doi: 10.1001/jama.2018.19323 – volume: 21 start-page: 86 issue: 1 year: 2014 end-page: 102 ident: CR9 article-title: Free radicals in cross talk between autophagy and apoptosis publication-title: Antioxid Redox Signal doi: 10.1089/ars.2013.5746 – volume: 25 start-page: 1037 issue: 5 year: 2017 end-page: 1043 ident: CR11 article-title: Autophagy and tumor metabolism publication-title: Cell Metab doi: 10.1016/j.cmet.2017.04.004 – volume: 428 start-page: 1659 year: 2016 end-page: 1680 ident: CR18 article-title: Mechanisms of selective autophagy in normal physiology and cancer publication-title: J Mol Biol doi: 10.1016/j.jmb.2016.02.027 – volume: 344 start-page: 174 issue: 2 year: 2014 end-page: 179 ident: CR27 article-title: p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents publication-title: Cancer Lett doi: 10.1016/j.canlet.2013.11.019 – volume: 287 start-page: 155 issue: 1–2 year: 2004 end-page: 162 ident: CR34 article-title: Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2004.08.015 – volume: 47 start-page: 154 issue: 1 year: 2019 end-page: 165 ident: CR15 article-title: Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors publication-title: Artif Cells Nanomed Biotechnol. doi: 10.1080/21691401.2018.1548468 – volume: 17 start-page: 395 issue: 7 year: 2020 end-page: 417 ident: CR3 article-title: Targeting apoptosis in cancer therapy publication-title: Nat Rev Clin Oncol doi: 10.1038/s41571-020-0341-y – volume: 2016 start-page: 5293284 year: 2016 ident: CR8 article-title: Roles of reactive oxygen species in anticancer therapy with bunge publication-title: Oxid Med Cell Longev doi: 10.1155/2016/5293284 – volume: 387 start-page: 95 year: 2017 end-page: 105 ident: CR23 article-title: Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals publication-title: Cancer Lett Ireland doi: 10.1016/j.canlet.2016.03.042 – volume: 38 start-page: 3599 issue: 6 year: 2017 end-page: 3607 ident: CR40 article-title: Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting β-catenin signaling publication-title: Oncol Rep – volume: 246 start-page: 13 year: 2017 end-page: 39 ident: CR2 article-title: Impact of albumin based approaches in nanomedicine: imaging, targeting and drug delivery publication-title: Adv Colloid Interface Sci doi: 10.1016/j.cis.2017.06.012 – year: 2017 ident: CR10 article-title: Inhibition of Autophagy promotes salinomycin-induced apoptosis via reactive oxygen species-mediated PI3K/AKT/mTOR and ERK/p38 MAPK-dependent signaling in human prostate cancer cells publication-title: Int J Mol Sci doi: 10.3390/ijms18051088 – volume: 164 start-page: 105387 year: 2021 ident: CR26 article-title: Baicalin mediated regulation of key signaling pathways in cancer publication-title: Pharmacol Res doi: 10.1016/j.phrs.2020.105387 – year: 2020 ident: CR1 article-title: Nanoparticle-mediated dual targeting: an approach for enhanced baicalin delivery to the liver publication-title: Pharmaceutics doi: 10.3390/pharmaceutics12020107 – volume: 7 start-page: 357 issue: 3 year: 2019 end-page: 367 ident: CR28 article-title: Albumin conjugates and assemblies as versatile bio-functional additives and carriers for biomedical applications publication-title: J Mater Chem B doi: 10.1039/C8TB02477D – volume: 246 start-page: 13 year: 2017 ident: 110_CR2 publication-title: Adv Colloid Interface Sci doi: 10.1016/j.cis.2017.06.012 – volume: 53 start-page: 2727 issue: 6 year: 2018 ident: 110_CR7 publication-title: Int J Oncol – volume: 387 start-page: 95 year: 2017 ident: 110_CR23 publication-title: Cancer Lett Ireland doi: 10.1016/j.canlet.2016.03.042 – volume: 27 start-page: 1128 issue: 4 year: 2012 ident: 110_CR36 publication-title: Oncol Rep doi: 10.3892/or.2011.1599 – volume: 19 start-page: 12 issue: 1 year: 2020 ident: 110_CR14 publication-title: Mol Cancer doi: 10.1186/s12943-020-1138-4 – volume: 45 start-page: 245 issue: 1 year: 2020 ident: 110_CR32 publication-title: Int J Mol Med – volume: 17 start-page: 395 issue: 7 year: 2020 ident: 110_CR3 publication-title: Nat Rev Clin Oncol doi: 10.1038/s41571-020-0341-y – volume: 287 start-page: 155 issue: 1–2 year: 2004 ident: 110_CR34 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2004.08.015 – volume: 344 start-page: 174 issue: 2 year: 2014 ident: 110_CR27 publication-title: Cancer Lett doi: 10.1016/j.canlet.2013.11.019 – volume: 8 start-page: 579 issue: 7 year: 2009 ident: 110_CR29 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2803 – volume: 12 start-page: 3247 year: 2018 ident: 110_CR41 publication-title: Drug Des Devel Ther doi: 10.2147/DDDT.S176403 – volume: 428 start-page: 1659 year: 2016 ident: 110_CR18 publication-title: J Mol Biol doi: 10.1016/j.jmb.2016.02.027 – volume: 10 start-page: 255 issue: 4 year: 2019 ident: 110_CR37 publication-title: Cell Death Dis doi: 10.1038/s41419-019-1492-6 – volume: 47 start-page: 154 issue: 1 year: 2019 ident: 110_CR15 publication-title: Artif Cells Nanomed Biotechnol. doi: 10.1080/21691401.2018.1548468 – volume: 16 start-page: 8729 issue: 6 year: 2017 ident: 110_CR6 publication-title: Mol Med Rep doi: 10.3892/mmr.2017.7757 – volume: 12 start-page: 11183 year: 2019 ident: 110_CR5 publication-title: Onco Targets Ther doi: 10.2147/OTT.S217101 – volume: 164 start-page: 105387 year: 2021 ident: 110_CR26 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2020.105387 – volume: 5 start-page: 669 year: 2010 ident: 110_CR38 publication-title: Int J Nanomedicine – volume: 63 start-page: 51 issue: 1 year: 2011 ident: 110_CR24 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2010.10.012 – volume: 7 start-page: 357 issue: 3 year: 2019 ident: 110_CR28 publication-title: J Mater Chem B doi: 10.1039/C8TB02477D – volume: 30 start-page: 1648 issue: 12 year: 2009 ident: 110_CR39 publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2009.166 – volume: 22 start-page: 1321 issue: 11 year: 2017 ident: 110_CR42 publication-title: Apoptosis doi: 10.1007/s10495-017-1424-9 – volume: 70 start-page: 7 issue: 1 year: 2020 ident: 110_CR25 publication-title: CA Cancer J Clin doi: 10.3322/caac.21590 – volume: 257 start-page: 169 issue: 1–2 year: 2003 ident: 110_CR12 publication-title: Int J Pharm doi: 10.1016/S0378-5173(03)00134-0 – volume: 65 start-page: 102603 year: 2021 ident: 110_CR19 publication-title: J Drug Deliv Sci Technol. doi: 10.1016/j.jddst.2021.102603 – volume: 321 start-page: 288 issue: 3 year: 2019 ident: 110_CR30 publication-title: JAMA doi: 10.1001/jama.2018.19323 – volume: 467 start-page: 1 issue: 1–2 year: 2020 ident: 110_CR33 publication-title: Mol Cell Biochem doi: 10.1007/s11010-019-03667-9 – volume: 36 start-page: 489 year: 2018 ident: 110_CR21 publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-042617-053010 – volume: 25 start-page: 1037 issue: 5 year: 2017 ident: 110_CR11 publication-title: Cell Metab doi: 10.1016/j.cmet.2017.04.004 – volume: 38 start-page: 3599 issue: 6 year: 2017 ident: 110_CR40 publication-title: Oncol Rep – volume: 11 start-page: 381 issue: 1 year: 2016 ident: 110_CR13 publication-title: Nanoscale Res Lett doi: 10.1186/s11671-016-1586-3 – volume: 33 start-page: 1193 issue: 8 year: 2010 ident: 110_CR35 publication-title: Arch Pharm Res doi: 10.1007/s12272-010-0809-x – year: 2019 ident: 110_CR4 publication-title: Nutrients doi: 10.3390/nu11071514 – volume: 14 start-page: 251 issue: 1 year: 2015 ident: 110_CR22 publication-title: Iran J Pharm Res – year: 2020 ident: 110_CR1 publication-title: Pharmaceutics doi: 10.3390/pharmaceutics12020107 – volume: 80 start-page: 50 year: 2018 ident: 110_CR20 publication-title: Semin Cell Dev Biol doi: 10.1016/j.semcdb.2017.05.023 – volume: 21 start-page: 86 issue: 1 year: 2014 ident: 110_CR9 publication-title: Antioxid Redox Signal doi: 10.1089/ars.2013.5746 – volume: 35 start-page: 57 issue: 1 year: 2009 ident: 110_CR17 publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2008.09.005 – volume: 121 start-page: 109139 year: 2020 ident: 110_CR31 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2019.109139 – volume: 11 start-page: 2863 issue: 29 year: 2020 ident: 110_CR16 publication-title: Oncotarget doi: 10.18632/oncotarget.27677 – year: 2017 ident: 110_CR10 publication-title: Int J Mol Sci doi: 10.3390/ijms18051088 – volume: 2016 start-page: 5293284 year: 2016 ident: 110_CR8 publication-title: Oxid Med Cell Longev doi: 10.1155/2016/5293284 |
SSID | ssj0000399909 |
Score | 2.4166584 |
Snippet | Background
Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous... BackgroundBreast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous... Abstract Background Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor... |
SourceID | doaj proquest crossref springer |
SourceType | Open Website Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 1 |
SubjectTerms | Albumin nanoparticles Albumins Antiproliferatives Apoptosis Autophagy Baicalin Biochemistry Biomedical Engineering and Bioengineering Breast cancer Cancer Research Cell cycle Chemistry and Materials Science Flow cytometry Fluorescence Folic acid Materials Science Nanoparticles Nanotechnology Proteins Signal pathway Signaling |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLAgpioSAfegCBtYmT-HHMVqyqom2rdpF6i_xEUdtsxW6h_SX8XWacbB9IwIWr40jWeJz5Jv7mG0K2veM6D0YzFW3FsBQSzpwOzFkXdFFKV_rEttgXu1_KvZPq5E6rL-SE9fLAveHGxqnouLMQiUzprddWVTEXiiM_UcdU5pvp7E4ylb7BEHd14negHDwTulLrihklxsscYAAWJkMmjfGPXd2LSkm8_x7i_O2SNMWe6RPyeACNtO4X-5Q8CN0z8nA2XItvkp8Tg7ZuO3a2MD54GlHtlxrXena-8G0EnEkTEbntaGc6SJQHPhx9N63Z5LjeP1yOJ_V7Chk67DU1l6g3YL5ewwCd7UyZpPiHf0m_t4YeHRyzVHACYJVeFIrO6sPP1HSe1qer8fn84Ihin-Mf5vo5mU8_zXd22dBxgTmISyuWV0bH3BUui8L7MuaVDNHkXkUOgY5nPgA-slJa5SR2UjBOKBG1siKg6E_xgmx0iy68JLTgUkcuVfDclDZKa3n0wRRRRlsarUYkXxu8cYMaOTbFOGtSVqJE029SA5uUeHdZczUiH27euei1OP46e4L7eDMTdbTTAHhXM1i5-Zd3jcjW2gua4XAvGxSxB5gK0G9EPq494_bxn5f06n8s6TV5xLEEI1FqtsjG6ttleAPAaGXfpjPwC50QBSg priority: 102 providerName: Directory of Open Access Journals – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxELZQkRAXVF4iUJAPHEBgJevd9eO4iYgqUNqqDVJvlp9oRbupSFroL-HvMuNsAkWAxNXrXVme8c43nplvCHkZPNdFtJqp5GqGpZBw5nRk3vmoy0r6KuRsiwOx_7F6f1qf9jQ5WAvza_y-UGK4LMBiYw0xOL1oqhjgxds1_HhRmydisr1PGYGl1TmjAwngmdC12tTI_PEzN-xQpuu_gTF_C4tmazPdJfd6mEibtVzvk1uxe0DuzPpA-EPyfWxxd9uOnS1siIEm5Pel1reBnS9CmwBZ0px63Ha0sx24xn0GHH01bdj4pDk4Wg7HzWsKPjlIl9pLZBiwn65hgM4mUyYp3ukv6VVr6fHhCcslJgBP6UWp6Kw5-kBtF2jzeTU8nx8eU-xs_NVePyLz6bv5ZJ_1PRaYB0u0YkVtdSp86UdJhFClopYx2SKoxMG08VGIgIiclE55ib0TrBdKJK2ciEjzUz4mO92ii08ILbnUiUsVA7eVS9I5nkK0ZZLJVVarASk2G258zz-ObTDOTPZDlDBrIRkQUs60G5lvA_Jm-87Fmn3jn7PHKMftTGTOzgOgUKbfZWO9Sp57B8jGVsEF7VSdCqE45rvqBMvc22iB6Y_z0iBtPQBTAHsD8najGT8f_31JT_9v-jNyl2N5RU6X2SM7qy-X8TmAnpV7kbX9B2xZ9VY priority: 102 providerName: Springer Nature |
Title | Baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) induce autophagy in MCF-7 cells via ROS-mediated p38 MAPK and Akt/mTOR pathway |
URI | https://link.springer.com/article/10.1186/s12645-021-00110-x https://www.proquest.com/docview/2617112172 https://doaj.org/article/ac8fc2cb181a4dbd9b85f168241059f8 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LaxsxEBZtAqWX0id1mxodemhphb3y7ko6lbWJG1zsGNuB3BY9g0mydmOnTX5J_25n5LVDCs1FC1rtIjSS5tNo5htCPjrLVeK1YjKYjGEoJKw55Zk11qtOKmzqorfFKD86SQen2WltcFvVbpXbPTFu1G5h0UbeQuZwwAagb78tfzLMGoW3q3UKjcdkPwEkgqkbxKnY2VjaoH1V9PJAUniWq0xu42Zk3lolAAYwPBnO06gF2c093RQp_O_hzn-uSqMG6j8nz2roSIuNrF-QR756SZ4M68vxV-RPV-OIzyt2sdDOOxqQ85dqO3fscuHmAdAmje7I84pWuoLjcu0VRz_1C9adFqPxqtUtPlM4p4PEqb5G1gF9dgsVdNjrM0HRzr-iv-aaTo6nLIadAGSly46kw2L8g-rK0eJ83bqcHU8oZjv-rW9fk1n_cNY7YnXeBWZBO61ZkmkVEtux7ZA7l4YkEz7oxMnAQd3xtvOAkowQRlqB-RS0zWUelDS5R-qfzhuyVy0q_5bQDhcqcCG94zo1QRjDg_O6E0QwqVayQZLtgJe25iTH1BgXZTybyLzcCKkEIUXvu3Z50yBfdt8sN4wcD7buohx3LZFNO1Ysrs7KepRLbWWw3BpAOzp1xikjs5DkkqMPrArQzYPtLCjrJb4q7yZkg3zdzoy71__v0ruH__aePOUYYhFdZg7I3vrq2n8A4LM2zTi7oZT9702yXxSD6QCe3cPReAK1PZ5imfea0bAA5Qkv_gIaUwOd |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKKgEXxFMNFPABJBBYyXpf9qFCm9IoJU0apUHqbeVntaLdhCalzS_h1_Df8Di7qYpEb716vZblGc98tme-QeidVpQHRnDCrIwJpEK6PccNUVIZHkapirSPthgmve_Rt-P4eAP9qXNhIKyytoneUOupgjvyFjCHO2zg_O2X2U8CVaPgdbUuoSGq0gp6x1OMVYkdfbO8dEe4-c7-Vyfv95R29ya7PVJVGSDK2eIFCWLBbaBC1baJ1pEN4tRYEWhmqTPutK2NwwQyTSVTKVQPECphieVMJgaIbkI37D20GcH9SQNtdvaGo_H6kqft3D_3YSbASk8SHrM6cYclrXng0AjkR7sDPbhhcnXDOfoaAjeA7z9vtd4Fdh-jRxV2xdlK2Z6gDVM-RfcH1ev8M_S7I0DkRUlOp0IbjS2QDmOhCk3OprqwDu5iHw9dlLgUpTuvV2F5-EM3I52jbDiatzrZR1yU2qkcFhdAeyBOlq4BD3a7JMXw0DDHvwqBx4dHxOe9OMyMZyHDg2zUx6LUOPuxaJ1NDscYyi1fiuVzNLkLkbxAjXJami2EQ5pyS1NmNBWRtKmU1GojQptaGQnOmiioFzxXFSk61OY4zf3hiCX5Ski5E5IP_2vnV030af3PbEUJcmvvDshx3RPovH3D9Pwkr1Y5F4pZRZV0cEtEWmouWWyDhFEIwuXWTXO71oK8sjHz_HpHNNHnWjOuP_9_Si9vH-0tetCbDA7yg_1h_xV6SCHfw8fvbKPG4vzCvHYobCHfVLqOUX7Hu-svqek-ig |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcEE-RUmAPIIFglXj92j0g5LSYlpA0aoPUm7XPyqK1Q5PS5pfwW_h3zG7sVEWit17X9sryvL71fDOD0GutKA-M4IRZGRNXCgk2xw1RUhkeRqmKtGdbjJLd79HXo_hoDf1pa2EcrbL1id5R61q5f-Rd1zkcsAHE265taBHjnfzT9CdxE6RcprUdp7FUkYFZXMDxbfZxbwdk_YbS_PNke5c0EwaIAj88J0EsuA1UqHo20TqyQZwaKwLNLAXHTnvaAB6QaSqZSt3kAKESlljOZGJck5sQtr2D7qYhmIkrUs-_rH7v9CDwc08wcf3oScJj1pbssKQ7CwCHuMpoOMq7AEwur4VFPz3gGuT9J0vrg1_-AN1vUCvOlmr2EK2Z6hHaGDZ5-cfod184YZcVOamFNhpb124YC1Vqclrr0gLQxZ4JXVa4EhWc1BtCHn6bZ6R_mI3Gs24_e4fLSoOyYXHuGh6I4wUs4OF2TlLsUgwz_KsU-GD_kPiKF0DLeBoyPMzGAywqjbMf8-7pZP8Au0HLF2LxBE1uQyBP0XpVV-YZwiFNuaUpM5qKSNpUSmq1EaFNrYwEZx0UtB-8UE07dDeV46TwxyKWFEshFSAkT_zrFZcd9H71zHTZDOTGu_tOjqs7XSNvv1CfHRfNVy6EYlZRJQFoiUhLzSWLbZAw6ui33MJrbrVaUDTeZVZc2UIHfWg14-ry_19p8-bdXqENsKni295o8Bzdo67QwxN3ttD6_OzcvAD4NZcvvaJjVNyyYf0F4ko8Jg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Baicalin-loaded+folic+acid-modified+albumin+nanoparticles+%28FA-BSANPs%2FBA%29+induce+autophagy+in+MCF-7+cells+via+ROS-mediated+p38+MAPK+and+Akt%2FmTOR+pathway&rft.jtitle=Cancer+nanotechnology&rft.au=Liu+Fengjie&rft.au=Meng%2C+Lan&rft.au=Ren+Baoqi&rft.au=Li%2C+Lihong&rft.date=2022-12-01&rft.pub=Springer+Nature+B.V&rft.issn=1868-6958&rft.eissn=1868-6966&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1186%2Fs12645-021-00110-x&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1868-6958&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1868-6958&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1868-6958&client=summon |